| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |